anti-arrhythmia drug
A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres.
|
|
1-(2,6-dimethylphenoxy)propan-2-amine hydrochloride
|
1-(2,6-dimethylphenoxy)propan-2-aminium chloride
|
(±)-1-methyl-2-(2,6-xylyloxy)ethylamine hydrochloride
|
ChemIDplus
|
1-(2,6-dimethylphenoxy)-2-aminopropane hydrochloride
|
ChemIDplus
|
1-(2,6-dimethylphenoxy)-2-propanamine hydrochloride
|
ChemIDplus
|
1-methyl-2-(2,6-xylyloxy)ethylamine hydrochloride
|
ChemIDplus
|
1-methyl-2-(2,6-xylyloxy)ethylammonium chloride
|
ChemIDplus
|
mexiletine HCl
|
ChemIDplus
|